A phase II trial of bisantrene (CL216,942) in refractory epithelial ovarian cancer
John J. Kavanagh, David M. Gershenson, Patton B. Saul, Larry J. CopelandVolume:
23
Year:
1986
Language:
english
DOI:
10.1016/0090-8258(86)90113-7
File:
PDF, 199 KB
english, 1986